Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2023

Stockholders' Equity Note [Abstract]

Schedule of Stock Options Activity

A summary of the stock option activity under the Company’s equity incentive plans is presented below:

	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Term	Aggregate Intrinsic Value
Balance as of December 31, 2022	3,976	$	6.20	3.80	$	—
Granted	57	0.61		—	—
Exercised	(34)	0.86		—	—
Forfeited	(167)	5.17		—	—
Expired	(358)	5.41		—	—
Balance as of September 30, 2023	3,474	$	6.29	2.89	$	—
Expected to vest at September 30, 2023	3,474	$	6.29	2.89	$	—
Exercisable at September 30, 2023	3,077	$	6.50	2.17	$	—

Schedule of RSU Activity

A summary of Restricted Stock Unit (“RSU”) activity is presented below:

	Shares	Weighted Average Grant- Date Fair Value
Outstanding as of December 31, 2022	7,495	$	3.59
Granted	9,373	0.63
Vested	(3,642)	3.25
Forfeited	(1,713)	3.78
Outstanding as of September 30, 2023	11,513	$	1.26

Summary of Stock-Based Compensation Expense

The following table summarizes stock-based compensation cost included in the condensed consolidated statements of operations:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Cost of revenue, excluding depreciation and amortization	$	272	$	460	$	883	$	3,615
Sales and marketing	261		550		1,148		2,663
General and administrative	1,191		2,448		3,345		8,828
Research and development1	75		177		(198)		3,753
Total	$	1,799	$	3,635	$	5,178	$	18,859

_________________________________

(1) The negative stock-based compensation expense for the nine months ended September 30, 2023 for Research and development was due to forfeitures.